Analysis of uveitis causes and treatment approaches
Lyon Uveitis Study
This study looks at the causes and treatment options for uveitis to help doctors better care for patients and prevent serious vision problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon) |
| Trial ID | NCT03877575 on ClinicalTrials.gov |
What this trial studies
The Lyon Uveitis Study aims to analyze the ophthalmologic etiology and the diagnostic and therapeutic care of patients diagnosed with uveitis. This observational study collects clinical data from patients referred to the Department of Internal Medicine at Croix Rousse Hospital in Lyon, France. By examining patient characteristics and the relevance of complementary exams, the study seeks to improve understanding and management of uveitis, which can lead to blindness if not properly treated.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with uveitis who are attending their first consultation at the Department of Internal Medicine at Croix-Rousse Hospital.
Not a fit: Patients who do not have a diagnosis of uveitis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance diagnostic accuracy and treatment strategies for uveitis, potentially reducing the risk of blindness.
How similar studies have performed: While this study focuses on observational data collection, similar studies have shown success in improving understanding and treatment of uveitis.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of uveitis * First consultation in the Department of Internal Medicine at the Croix-Rousse hospital, Lyon, France Exclusion Criteria: -
Where this trial is running
Lyon
- Department of Internal Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon — Lyon, France (Recruiting)
Study contacts
- Study coordinator: Pascal Sève, MD, PhD
- Email: pascal.seve@chu-lyon.fr
- Phone: +33-4 26 73 26 27
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.